150 related articles for article (PubMed ID: 35866762)
21. Long-term outcome and prognostic factors for yolk sac tumor of the ovary.
Umezu T; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Kikkawa F
Nagoya J Med Sci; 2008 Mar; 70(1-2):29-34. PubMed ID: 18807293
[TBL] [Abstract][Full Text] [Related]
22. Fertility-sparing surgery for patients with malignant ovarian germ cell tumors: 10 years of clinical experience from a tertiary referral center.
Mikuš M; Benco N; Matak L; Planinić P; Ćorić M; Lovrić H; Radošević V; Puževski T; Bajt M; Vujić G
Arch Gynecol Obstet; 2020 May; 301(5):1227-1233. PubMed ID: 32253553
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors of patients with yolk sac tumors of the ovary.
Nawa A; Obata N; Kikkawa F; Kawai M; Nagasaka T; Goto S; Nishimori K; Nakashima N
Am J Obstet Gynecol; 2001 May; 184(6):1182-8. PubMed ID: 11349186
[TBL] [Abstract][Full Text] [Related]
24. Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study.
Mangili G; Sigismondi C; Gadducci A; Cormio G; Scollo P; Tateo S; Ferrandina G; Greggi S; Candiani M; Lorusso D
Int J Gynecol Cancer; 2011 Nov; 21(8):1414-21. PubMed ID: 21795985
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors of patients with ovarian yolk sac tumors: a study in Chinese patients.
Tong X; You Q; Li L; Cai L; Wang C; Zheng J
Onkologie; 2008 Dec; 31(12):679-84. PubMed ID: 19060506
[TBL] [Abstract][Full Text] [Related]
26. Imaging in gynecological disease (17): ultrasound features of malignant ovarian yolk sac tumors (endodermal sinus tumors).
Anfelter P; Testa A; Chiappa V; Froyman W; Fruscio R; Guerriero S; Alcazar JL; Mascillini F; Pascual MA; Sibal M; Savelli L; Zannoni GF; Timmerman D; Epstein E
Ultrasound Obstet Gynecol; 2020 Aug; 56(2):276-284. PubMed ID: 32119168
[TBL] [Abstract][Full Text] [Related]
27. Yolk sac tumours of the ovary: an update.
Dällenbach P; Bonnefoi H; Pelte MF; Vlastos G
Eur J Surg Oncol; 2006 Dec; 32(10):1063-75. PubMed ID: 16996238
[TBL] [Abstract][Full Text] [Related]
28. Is fertility sparing surgery a treatment option for young patients with yolk sac tumor?
Iavazzo C; Vorgias G; Iavazzo PE; Minis EE; Gkegkes ID
Minerva Ginecol; 2018 Dec; 70(6):750-753. PubMed ID: 30465413
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of malignant ovarian germ-cell tumors treated in Chiang Mai University Hospital over a nine year period.
Neeyalavira V; Suprasert P
Asian Pac J Cancer Prev; 2014; 15(12):4909-13. PubMed ID: 24998562
[TBL] [Abstract][Full Text] [Related]
30. Reproductive function after treatment of ovarian germ cell malignancy.
Anita AN; Rushdan MN
Med J Malaysia; 2012 Feb; 67(1):71-6. PubMed ID: 22582552
[TBL] [Abstract][Full Text] [Related]
31. Ovarian endometrioid tumors with yolk sac tumor component, an unusual form of ovarian neoplasm. Analysis of six cases.
Nogales FF; Bergeron C; Carvia RE; Alvaro T; Fulwood HR
Am J Surg Pathol; 1996 Sep; 20(9):1056-66. PubMed ID: 8764742
[TBL] [Abstract][Full Text] [Related]
32. Reproductive outcomes after conservative treatment in early and advanced stage MOGCTs.
Vasta FM; Cormio G; Cassani C; Bergamini A; Scarfone G; Ferrandina G; De Vivo R; Marinaccio M; Danese S; Raspagliesi F; Pignata S; Mangili G
Gynecol Oncol; 2024 Feb; 181():28-32. PubMed ID: 38104526
[TBL] [Abstract][Full Text] [Related]
33. Pregnancy and Delivery After Ovarian Yolk Sac Tumor: A Case Report.
Alrjoub MM; Sindiani A; Alshriedeh O; Amarin Z
Am J Case Rep; 2021 Aug; 22():e932091. PubMed ID: 34408122
[TBL] [Abstract][Full Text] [Related]
34. Germ Cell Tumor Ovary: an Institutional Experience of Treatment and Survival Outcomes.
Lakshmanan M; Gupta S; Kumar V; Akhtar N; Chaturvedi A; Misra S; Jain K; Garg S
Indian J Surg Oncol; 2018 Jun; 9(2):215-219. PubMed ID: 29887704
[TBL] [Abstract][Full Text] [Related]
35. Long-term oncological and reproductive outcomes of fertility-sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors.
Ertas IE; Taskin S; Goklu R; Bilgin M; Goc G; Yildirim Y; Ortac F
J Obstet Gynaecol Res; 2014 Mar; 40(3):797-805. PubMed ID: 24320102
[TBL] [Abstract][Full Text] [Related]
36. Ovarian Yolk Sac Tumor: The Experience of a Regional Cancer Center.
Wang X; Ma Z; Li Y
Int J Gynecol Cancer; 2016 Jun; 26(5):884-91. PubMed ID: 27104939
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of Surgery Alone and Surveillance Strategy in Young Women With Stage I Malignant Ovarian Germ Cell Tumors.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Int J Gynecol Cancer; 2016 Jun; 26(5):859-64. PubMed ID: 27101582
[TBL] [Abstract][Full Text] [Related]
38. MALIGNANT OVARIAN GERM CELL TUMORS AT A TERTIARY CARE SETTING IN PAKISTAN.
Hannan A; Malik MA; Fasih S; Badar F; Siddiqui N
J Ayub Med Coll Abbottabad; 2015; 27(3):624-7. PubMed ID: 26721024
[TBL] [Abstract][Full Text] [Related]
39. [Prognosis and fertility outcomes of patients with borderline ovarian tumors after fertility-sparing surgery].
Zhang Y; Wang QN; Huang Z; Chu R; Dong TT; Zhang YZ; Yang XS; Jiang J; Cui BX; Song K; Kong B
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(26):1999-2004. PubMed ID: 35817724
[No Abstract] [Full Text] [Related]
40. Primary yolk sac tumor of the endometrium: a case report and review of the literatures.
Lu T; Qi L; Ma Y; Lu G; Zhang X; Liu P
Arch Gynecol Obstet; 2019 Nov; 300(5):1177-1187. PubMed ID: 31549219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
